Health and Me

Tanya Dutt

FDA Approves First Glucose Monitoring System For Weight Loss, But Should People Who Don’t Have Diabetes Wear It?

The Food and Drug Administration just approved the first-ever glucose monitoring system specifically for weight loss, establishing a new option for Americans to manage their weight. Until now, the main options have been expensive obesity drugs like Wegovy and Zepbound or surgical interventions both usually limited to people with a certain BMI. Even then, access is tough: high price tags, patchy insurance coverage, and limited supply often put these treatments out of reach.

Could a wearable device that tracks your body’s glucose in real time open up a more accessible, personalized way to manage weight? This approval suggests the answer might finally be yes.

Continuous glucose monitors (CGMs) were designed as lifesaving devices for people living with diabetes. They eliminate the need for constant finger-prick tests, instead offering near real-time blood sugar readings through a small wearable sensor. For individuals managing type 1 diabetes, type 2 diabetes on insulin, or gestational diabetes, this technology has transformed daily life—improving safety, flexibility, and long-term health outcomes.

But lately, CGMs are appearing on the arms of people who don’t have diabetes. Celebrities, elite athletes, and wellness influencers are adopting these devices in the name of performance, longevity, or “biohacking.” While the movement reflects a growing cultural obsession with data-driven health, experts are increasingly asking: is this medical technology being used responsibly—or is it being misapplied in ways that provide more confusion than clarity?

To understand the debate, it helps to revisit the basics. Glucose is the body’s main source of energy, fueling muscle, brain, and organ function. Think of it like gasoline for a car: too little, and the system stalls; too much, and long-term damage builds up.

In healthy individuals, the body keeps glucose within a safe range by releasing insulin, a hormone made in the pancreas that helps shuttle glucose from the bloodstream into cells. For those with diabetes, this regulatory system is impaired, which makes constant monitoring critical.

Even without diabetes, blood sugar naturally fluctuates throughout the day depending on meals, physical activity, stress, illness, or even puberty. These swings are normal. What’s not normal is chronic dysregulation—something CGMs were designed to help patients detect and manage.

<h2>How Continuous Glucose Monitors Work?</h2>

Traditionally, people with diabetes relied on finger-prick testing several times a day. CGMs replaced much of that burden. A small sensor, often worn on the arm or abdomen, measures glucose levels in the fluid between cells every few minutes. The data is sent to a reader or smartphone app, allowing patients to track trends, prevent dangerous highs or lows, and adjust treatment accordingly.

For someone with type 1 diabetes, this technology can be the difference between life and death. It allows immediate action when glucose drops during sleep or spikes after meals. For pregnant women with gestational diabetes or people with type 2 diabetes on insulin, CGMs have also been shown to improve outcomes and reduce complications.

<h2>How Does A Wellness Tracker Work Without Diabetes?</h2>

Now, CGMs are crossing over into the wellness market. High-profile users—from tech CEOs to pro athletes—praise the devices for giving insights into how food, exercise, and stress affect their glucose patterns. Apps connected to CGMs often promise personalized nutrition advice or “metabolic optimization.”

There is some appeal: glucose spikes after eating highly processed carbohydrates or sugary foods can leave anyone feeling sluggish, and seeing that spike in real time can reinforce healthier food choices. For endurance athletes, monitoring glucose may help optimize fueling strategies during long events.

But the scientific evidence in support of CGM use among healthy individuals is lean. A 2022 study published by the University of the Sunshine Coast concluded that CGMs offered little clinically significant benefit for non-diabetic athletes. More recently, scientists examining international data in 2024 cautioned that promotional suggestions for CGM use in healthy populations might be "misleading," considering how little proven outcomes exist.

<h2>Is There Any Potential Downsides of Over-Monitoring</h2>

There's a second danger, information overload. For individuals who don't require vigilant watching, the data stream can cause worry or even unhealthy preoccupation. Every rise in blood sugar doesn't need a response—though some users might feel obligated to "correct" every spike, perhaps ending up on a restricting diet or feeling unduly anxious.

Its economic burden is also important. A CGM sensor with a life of just 14 days can be over $100 if it is not covered by insurance or public subsidies in the United States.For individuals without diabetes, that’s a steep price for information that may not translate into measurable health benefits.

Part of the fascination comes from the broader movement toward “biohacking” and quantified health. Wearables like smartwatches, sleep trackers, and fitness rings have made people more comfortable tracking biometric data daily. CGMs fit naturally into this landscape, offering a continuous metabolic data stream that feels cutting-edge and personalized.

Add in celebrity influence—musicians, influencers, and athletes openly wearing CGMs in interviews or on social media—and public interest has surged. For some, it represents empowerment: a way to take control of invisible processes in the body. For others, it’s simply the latest wellness trend in a crowded marketplace of supplements, gadgets, and health apps.

It’s worth noting why CGMs appeal to so many people. Nearly 74% of Americans are overweight or obese, according to government data, with obesity-related conditions costing the U.S. healthcare system more than $170 billion annually. With <span>metabolic health</span> under such strain, many are searching for tools to stay ahead of potential problems.

CGMs may feel like a proactive solution but experts caution that prevention is less about constant glucose monitoring and more about proven strategies: balanced nutrition, physical activity, adequate sleep, and routine medical check-ups. For now, CGMs aren’t a shortcut to better health if you don’t already have a condition requiring them.

<h2>Should People Without Diabetes Use CGMs?</h2>

The answer isn’t black and white. For individuals with diabetes, CGMs are life-changing and medically essential. For those without diabetes, the benefits are mostly speculative, while the risks anxiety, cost, and misuse of data are very real.

Health Conditions A-Z

health

continuous glucose monitor

cgm without diabetes

glucose tracking

blood sugar monitoring

wearable health tech

metabolic health

non diabetic cgm

7 Minutes Of Life: The Science Behind What Happens To Your Brain After You Die

Scientists Recreate Rare Mutation That Could Make You Nearly Immune To All Viruses

Better Diet Could Help Defeat Tuberculosis, Says ICMR Study Backed by WHO

Health News

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Superfoods That Support Your Gut Health

Immune-Boosting Foods To Have During Rainy Season

Potato Based Dishes You For Week-Long Meal Prep

Weight Loss Dishes With Fruits You Should Try

Stress Vs. Anxiety: Difference Explained In 60 seconds

Can You Get Heatstroke In Monsoon?

You’re Not Lazy! Women Do Need More Sleep Than Men

How To Ditch Daytime Sleepiness In Office?

Common Mistakes People Make While Eating Flaxseeds

Toddlers In India Are Missing Development Milestones: Study

Yoga Poses You Should Do For Back Pain

Healthy Brunch Ideas For A Lazy Weekend Meal

Balancing Exercises You Should Do For Stability

How Much Can Food Affect Menstruation?

What Should Fitness Look Like For A 13-18 Year Old

Food For Diabetes: What Should A Diabetic Diet Contain

You Don’t Always Need Weights For Strength Training

Feel Sleepy After Lunches - Light And Healthy Office Lunches

Positive Thinking Practice – How Does It Help You?

MIND Diet – Is This A Healthy Diet Or Another Trend?

Yoga Prop Essentials To Improve Your Exercise Session

The Food and Drug Administration just approved the first-ever glucose monitoring system specifically for weight loss, establishing a new option for Americans to manage their weight. Until now, the main options have been expensive obesity drugs like Wegovy and Zepbound or surgical interventions both usually limited to people with a certain BMI. Even then, access is tough: high price tags, patchy insurance coverage, and limited supply often put these treatments out of reach.Could a wearable device that tracks your body’s glucose in real time open up a more accessible, personalized way to manage weight? This approval suggests the answer might finally be yes.Continuous glucose monitors (CGMs) were designed as lifesaving devices for people living with diabetes. They eliminate the need for constant finger-prick tests, instead offering near real-time blood sugar readings through a small wearable sensor. For individuals managing type 1 diabetes, type 2 diabetes on insulin, or gestational diabetes, this technology has transformed daily life—improving safety, flexibility, and long-term health outcomes.But lately, CGMs are appearing on the arms of people who don’t have diabetes. Celebrities, elite athletes, and wellness influencers are adopting these devices in the name of performance, longevity, or “biohacking.” While the movement reflects a growing cultural obsession with data-driven health, experts are increasingly asking: is this medical technology being used responsibly—or is it being misapplied in ways that provide more confusion than clarity?What Is Glucose?To understand the debate, it helps to revisit the basics. Glucose is the body’s main source of energy, fueling muscle, brain, and organ function. Think of it like gasoline for a car: too little, and the system stalls; too much, and long-term damage builds up.In healthy individuals, the body keeps glucose within a safe range by releasing insulin, a hormone made in the pancreas that helps shuttle glucose from the bloodstream into cells. For those with diabetes, this regulatory system is impaired, which makes constant monitoring critical.Even without diabetes, blood sugar naturally fluctuates throughout the day depending on meals, physical activity, stress, illness, or even puberty. These swings are normal. What’s not normal is chronic dysregulation—something CGMs were designed to help patients detect and manage.How Continuous Glucose Monitors Work?Traditionally, people with diabetes relied on finger-prick testing several times a day. CGMs replaced much of that burden. A small sensor, often worn on the arm or abdomen, measures glucose levels in the fluid between cells every few minutes. The data is sent to a reader or smartphone app, allowing patients to track trends, prevent dangerous highs or lows, and adjust treatment accordingly.For someone with type 1 diabetes, this technology can be the difference between life and death. It allows immediate action when glucose drops during sleep or spikes after meals. For pregnant women with gestational diabetes or people with type 2 diabetes on insulin, CGMs have also been shown to improve outcomes and reduce complications.How Does A Wellness Tracker Work Without Diabetes?Now, CGMs are crossing over into the wellness market. High-profile users—from tech CEOs to pro athletes—praise the devices for giving insights into how food, exercise, and stress affect their glucose patterns. Apps connected to CGMs often promise personalized nutrition advice or “metabolic optimization.”There is some appeal: glucose spikes after eating highly processed carbohydrates or sugary foods can leave anyone feeling sluggish, and seeing that spike in real time can reinforce healthier food choices. For endurance athletes, monitoring glucose may help optimize fueling strategies during long events.But the scientific evidence in support of CGM use among healthy individuals is lean. A 2022 study published by the University of the Sunshine Coast concluded that CGMs offered little clinically significant benefit for non-diabetic athletes. More recently, scientists examining international data in 2024 cautioned that promotional suggestions for CGM use in healthy populations might be "misleading," considering how little proven outcomes exist.Is There Any Potential Downsides of Over-MonitoringThere's a second danger, information overload. For individuals who don't require vigilant watching, the data stream can cause worry or even unhealthy preoccupation. Every rise in blood sugar doesn't need a response—though some users might feel obligated to "correct" every spike, perhaps ending up on a restricting diet or feeling unduly anxious.Its economic burden is also important. A CGM sensor with a life of just 14 days can be over $100 if it is not covered by insurance or public subsidies in the United States.For individuals without diabetes, that’s a steep price for information that may not translate into measurable health benefits.Part of the fascination comes from the broader movement toward “biohacking” and quantified health. Wearables like smartwatches, sleep trackers, and fitness rings have made people more comfortable tracking biometric data daily. CGMs fit naturally into this landscape, offering a continuous metabolic data stream that feels cutting-edge and personalized.Add in celebrity influence—musicians, influencers, and athletes openly wearing CGMs in interviews or on social media—and public interest has surged. For some, it represents empowerment: a way to take control of invisible processes in the body. For others, it’s simply the latest wellness trend in a crowded marketplace of supplements, gadgets, and health apps.It’s worth noting why CGMs appeal to so many people. Nearly 74% of Americans are overweight or obese, according to government data, with obesity-related conditions costing the U.S. healthcare system more than $170 billion annually. With metabolic health under such strain, many are searching for tools to stay ahead of potential problems.CGMs may feel like a proactive solution but experts caution that prevention is less about constant glucose monitoring and more about proven strategies: balanced nutrition, physical activity, adequate sleep, and routine medical check-ups. For now, CGMs aren’t a shortcut to better health if you don’t already have a condition requiring them.Should People Without Diabetes Use CGMs?The answer isn’t black and white. For individuals with diabetes, CGMs are life-changing and medically essential. For those without diabetes, the benefits are mostly speculative, while the risks anxiety, cost, and misuse of data are very real.

fda approves first glucose monitoring system for weight loss, but should people who don’t have diabetes wear it?

Health & Wellness

From 'Frankenstein Rabbits' To 'Zombie Squirrels': What These Unsettling Traits Reveal About Parasitic Illnesses

from 'frankenstein rabbits' to 'zombie squirrels': what these unsettling traits reveal about parasitic illnesses

Unusual Side Effect Of COVID That Puts Women At Greater Health Risk

unusual side effect of covid that puts women at greater health risk

Japanese Scientists Discover Hidden Immune 'Hubs' That Could Cause Arthritis-Related Joint Damage

japanese scientists discover hidden immune 'hubs' that could cause arthritis-related joint damage

New ‘Off-the-Shelf’ Cancer Vaccine Shows Promising Results Against Deadly Pancreatic and Colorectal Cancers

new ‘off-the-shelf’ cancer vaccine shows promising results against deadly pancreatic and colorectal cancers

While viral diseases increase worldwide, scientists are uncovering breakthroughs that could shift the tide. A rare genetic mutation recreated in labs shows potential to make humans nearly immune to viruses, offering hope amid growing global health challenges. This discovery marks a critical step in reimagining future antiviral defenses. What if immunity to nearly all viruses wasn’t science fiction but a possibility hiding inside the cells of a few rare people? That’s the exciting promise scientists are now exploring after recreating a genetic mutation that seems to grant natural resistance to viral infections. In recent experiments, researchers used mRNA technology to mimic this mutation in animals, creating short-term but powerful antiviral protection. The findings, published in Science Translational Medicine, could change the way we prepare for pandemics and treat viral outbreaks.

The story begins with a rare immune disorder called ISG15 deficiency, first identified about 15 years ago by Columbia University immunologist Dusan Bogunovic. At first, the mutation seemed like bad news—it increased vulnerability to certain bacterial infections. But as more patients were studied, something unusual came into focus: these individuals rarely got seriously sick from viral diseases.

Flu, measles, mumps, chickenpox—patients carried evidence in their blood of past viral encounters, yet none recalled being laid up in bed or experiencing the kind of severe illness that typically accompanies these infections.

The secret was a constant, low-level immune activation. Normally, the body’s antiviral proteins are switched on only during an infection. But in ISG15-deficient people, the “on switch” never flips off. Their immune systems exist in a perpetual state of mild inflammation—enough to keep viruses from ever gaining a foothold.

<h2>From Rare Condition to Universal Antiviral Blueprint</h2>

For years, Bogunovic wondered if this quirk could be harnessed for broader use. “In the back of my mind, I kept thinking that if we could produce this type of light immune activation in other people, we could protect them from just about any virus,” he explained.

That theory now has proof of concept. Using technology similar to COVID-19 mRNA vaccines, Bogunovic’s team designed a therapy that temporarily reproduces the ISG15 effect in healthy animals. Instead of shutting down ISG15 completely—which produces dozens of proteins, not all beneficial—the researchers pinpointed 10 specific proteins responsible for antiviral resistance.

The therapy delivers mRNA instructions, wrapped in lipid nanoparticles, that prompt cells to make those proteins. The result: a body on viral high alert, but only for a few days.

<h2>Testing the Antiviral Shield in Animals</h2>

In experiments, mice and hamsters received the therapy via a nasal drip. When exposed to influenza and SARS-CoV-2, the animals’ bodies rapidly produced the antiviral proteins, which blocked the viruses at multiple stages of their life cycles.

The results were striking. Viral replication was restricted, disease severity dropped, and—crucially—the rest of the immune system functioned normally. Unlike people naturally born with ISG15 deficiency, the treated animals didn’t show harmful levels of inflammation.

Even more impressive: in lab cultures, no virus tested so far—including flu and coronaviruses—has managed to bypass the defense. “We have yet to find a virus that can break through the therapy’s defenses,” Bogunovic said.

<h2>Could This Work Like Powerful Protection For Viral Diseases?</h2>

The antiviral protection lasted three to four days—a short window, but potentially a lifesaving one in the right circumstances. Unlike vaccines, which take weeks to build immunity and must be tailored to specific pathogens, this therapy acts quickly and broadly.

That makes it especially promising for pandemic preparedness. Imagine health workers receiving a dose before entering a hospital during an outbreak, or family members protecting themselves while caring for a sick loved one. “We believe the technology will work even if we don’t know the identity of the virus,” Bogunovic said.

In effect, it could serve as a kind of biological personal protective equipment (PPE)—a temporary antiviral shield until traditional vaccines or treatments are developed.

For all its promise, the therapy faces steep challenges. Delivering mRNA precisely to where it’s needed in humans remains one of the toughest problems in biotechnology. In animals, the nasal route worked, but optimizing delivery for people is far from solved.

“Once the therapy reaches our cells, it works,” Bogunovic noted. “But the delivery of any nucleic acid, DNA or RNA, into the part of the body you want to protect is currently the biggest challenge in the field.”

There’s also the question of durability. Protection that lasts only a few days may limit practical use unless it can be safely repeated. Long-term effects on the immune system must also be carefully studied.

And then there’s public trust. The therapy relies on mRNA technology—the same platform behind COVID-19 vaccines—which has faced political and social backlash despite its scientific success. Convincing people to embrace another mRNA-based innovation could be difficult.

Despite these obstacles, the implications are profound. If scientists can refine and safely scale this approach, it could give humanity an entirely new tool against viral threats one not limited to known pathogens or dependent on predicting the next pandemic strain.

Bogunovic envisions a world where doctors could deploy the therapy in nursing homes during flu season, where first responders could be inoculated at the front lines of outbreaks, and where households could shield vulnerable family members when new viruses emerge.

“Our findings reinforce the power of research driven by curiosity without preconceived notions,” Bogunovic said. “We were not looking for an antiviral when we began studying our rare patients, but the studies have inspired the potential development of a universal antiviral for everyone.”

Only a few dozen people on Earth naturally carry the ISG15 mutation, but their biology may unlock a universal antiviral strategy for the rest of us. For now, the work is confined to labs and animal trials But the concept that a rare genetic glitch could be recreated to protect against virtually any virus is a remarkable reminder of how much nature still has to teach us.

virus outbreak

viral illness

universal virus immunity

rare mutation antiviral

columbia scientists discovery

antiviral breakthrough

virus protection research

pandemic future cure

genetic mutation immunity

While viral diseases increase worldwide, scientists are uncovering breakthroughs that could shift the tide. A rare genetic mutation recreated in labs shows potential to make humans nearly immune to viruses, offering hope amid growing global health challenges. This discovery marks a critical step in reimagining future antiviral defenses. What if immunity to nearly all viruses wasn’t science fiction but a possibility hiding inside the cells of a few rare people? That’s the exciting promise scientists are now exploring after recreating a genetic mutation that seems to grant natural resistance to viral infections. In recent experiments, researchers used mRNA technology to mimic this mutation in animals, creating short-term but powerful antiviral protection. The findings, published in Science Translational Medicine, could change the way we prepare for pandemics and treat viral outbreaks.The story begins with a rare immune disorder called ISG15 deficiency, first identified about 15 years ago by Columbia University immunologist Dusan Bogunovic. At first, the mutation seemed like bad news—it increased vulnerability to certain bacterial infections. But as more patients were studied, something unusual came into focus: these individuals rarely got seriously sick from viral diseases.Flu, measles, mumps, chickenpox—patients carried evidence in their blood of past viral encounters, yet none recalled being laid up in bed or experiencing the kind of severe illness that typically accompanies these infections.The secret was a constant, low-level immune activation. Normally, the body’s antiviral proteins are switched on only during an infection. But in ISG15-deficient people, the “on switch” never flips off. Their immune systems exist in a perpetual state of mild inflammation—enough to keep viruses from ever gaining a foothold.From Rare Condition to Universal Antiviral BlueprintFor years, Bogunovic wondered if this quirk could be harnessed for broader use. “In the back of my mind, I kept thinking that if we could produce this type of light immune activation in other people, we could protect them from just about any virus,” he explained.That theory now has proof of concept. Using technology similar to COVID-19 mRNA vaccines, Bogunovic’s team designed a therapy that temporarily reproduces the ISG15 effect in healthy animals. Instead of shutting down ISG15 completely—which produces dozens of proteins, not all beneficial—the researchers pinpointed 10 specific proteins responsible for antiviral resistance.The therapy delivers mRNA instructions, wrapped in lipid nanoparticles, that prompt cells to make those proteins. The result: a body on viral high alert, but only for a few days.Testing the Antiviral Shield in AnimalsIn experiments, mice and hamsters received the therapy via a nasal drip. When exposed to influenza and SARS-CoV-2, the animals’ bodies rapidly produced the antiviral proteins, which blocked the viruses at multiple stages of their life cycles.The results were striking. Viral replication was restricted, disease severity dropped, and—crucially—the rest of the immune system functioned normally. Unlike people naturally born with ISG15 deficiency, the treated animals didn’t show harmful levels of inflammation.Even more impressive: in lab cultures, no virus tested so far—including flu and coronaviruses—has managed to bypass the defense. “We have yet to find a virus that can break through the therapy’s defenses,” Bogunovic said.Could This Work Like Powerful Protection For Viral Diseases?The antiviral protection lasted three to four days—a short window, but potentially a lifesaving one in the right circumstances. Unlike vaccines, which take weeks to build immunity and must be tailored to specific pathogens, this therapy acts quickly and broadly.That makes it especially promising for pandemic preparedness. Imagine health workers receiving a dose before entering a hospital during an outbreak, or family members protecting themselves while caring for a sick loved one. “We believe the technology will work even if we don’t know the identity of the virus,” Bogunovic said.In effect, it could serve as a kind of biological personal protective equipment (PPE)—a temporary antiviral shield until traditional vaccines or treatments are developed.For all its promise, the therapy faces steep challenges. Delivering mRNA precisely to where it’s needed in humans remains one of the toughest problems in biotechnology. In animals, the nasal route worked, but optimizing delivery for people is far from solved.“Once the therapy reaches our cells, it works,” Bogunovic noted. “But the delivery of any nucleic acid, DNA or RNA, into the part of the body you want to protect is currently the biggest challenge in the field.”There’s also the question of durability. Protection that lasts only a few days may limit practical use unless it can be safely repeated. Long-term effects on the immune system must also be carefully studied.And then there’s public trust. The therapy relies on mRNA technology—the same platform behind COVID-19 vaccines—which has faced political and social backlash despite its scientific success. Convincing people to embrace another mRNA-based innovation could be difficult.Despite these obstacles, the implications are profound. If scientists can refine and safely scale this approach, it could give humanity an entirely new tool against viral threats one not limited to known pathogens or dependent on predicting the next pandemic strain.Bogunovic envisions a world where doctors could deploy the therapy in nursing homes during flu season, where first responders could be inoculated at the front lines of outbreaks, and where households could shield vulnerable family members when new viruses emerge.“Our findings reinforce the power of research driven by curiosity without preconceived notions,” Bogunovic said. “We were not looking for an antiviral when we began studying our rare patients, but the studies have inspired the potential development of a universal antiviral for everyone.”Only a few dozen people on Earth naturally carry the ISG15 mutation, but their biology may unlock a universal antiviral strategy for the rest of us. For now, the work is confined to labs and animal trials But the concept that a rare genetic glitch could be recreated to protect against virtually any virus is a remarkable reminder of how much nature still has to teach us.

scientists recreate rare mutation that could make you nearly immune to all viruses

Aarushi Bhadury

Legionnaires' Outbreak Sickened 108 And Kills 5 In New York City: Can It Spread From Person To Person?

Legionnaires' Outbreak Sickened 108 And Kills 5 In New York City

Valley Fever Cases Rise In West Coast, California Health Officials Warn Residents To Stay Alert, Know Symptoms

valley fever cases rise in west coast, california health officials warn residents to stay alert, know symptoms

9-Year-Old Passes Away In Kerala Due To 'Brain Eating Amoeba' Infection: How To Spot The First Symptom?

9-year-old passes away in kerala due to 'brain eating amoeba', symptoms, risk factors and treatment

Two Premature Infants Die From Infection In Italy Hospital Over Suspected Soap Dish Contamination

two premature infants die from infection in italy hospital over suspected soap dish contamination

Unique Symptoms Of Lyme Disease In 2025 And How Long Infection Now Last

unique symptoms of lyme disease in 2025 and how long infection now last

A recent outbreak of <span>Legionnaires</span>’ disease in <span>Central Harlem</span>, a neighborhood in <span>New York City</span>, has led to a number of illnesses and some deaths. So far, five people have died, and over 100 people have been confirmed to be sick. 

The city's health department has been tracking the outbreak since it began in late July. They've found that the number of new cases is going down, which suggests their efforts to clean up the source have been working. Still, they are continuing to investigate and monitor the situation. 

The outbreak was traced back to cooling towers in the area. Cooling towers are a part of a building's air conditioning system that uses water to help cool it down. The city health department tested all the cooling towers in the affected areas and found that 12 of them had the bacteria. They have all since been cleaned and treated. Health officials have said that the issue is with the cooling towers, not with the regular hot or cold water in the buildings, and that it's safe for people to continue using their air conditioners. 

<h2>Can It Spread From Person To Person Contact? </h2>

Legionnaires' disease is not contagious, so you can't get it from another person. The disease is mainly spread when someone breathes in tiny water droplets (called aerosols) that are contaminated with the <span>Legionella</span> bacteria. 

While it's not common, you can also be exposed by breathing in contaminated soil or, in rare cases, by accidentally breathing in water while drinking it. 

Whether a person gets sick after exposure depends on a few things: their overall health, how much of the bacteria is in the air they breathe, and how contaminated the source of the bacteria is. 

<h2>What Caused The Sudden Surge In Numbers? </h2>

As of Monday, 14 people were hospitalized according to the health department. However, within the span of 5 days the number of infections has jumped to 108 people. Harlem City Councilmember Yusef Salaam, in a press conference last week urges people to visit the doctor if they exhibit any flu-like symptom to visit the doctor. 

"This is the time for you to actually go and seek medical attention. That's how serious this is." 

<h2>How Long Does It Take For Legionnaires Symptoms To Appear? </h2>

Legionnaires’ disease is a serious type of lung infection, or pneumonia. People can get sick by breathing in tiny water droplets that contain the bacteria. The symptoms can take up to two weeks to appear and often feel like a bad case of the flu, including a cough, fever, chills, headaches, and muscle aches. The disease got its name from an outbreak in 1976 among a group of veterans at a convention. While the disease is not very common, it is becoming more of a concern nationwide, with research suggesting that hotter, more humid weather might be a reason for the increase in cases. 

legionella

new york city

central harlem

legionnaires

Legionnaires Outbreak

Legionnaires Outbreak New york

Legionnaires Risk

what caused the Legionnaires Outbreak

A recent outbreak of Legionnaires’ disease in Central Harlem, a neighborhood in New York City, has led to a number of illnesses and some deaths. So far, five people have died, and over 100 people have been confirmed to be sick. The city's health department has been tracking the outbreak since it began in late July. They've found that the number of new cases is going down, which suggests their efforts to clean up the source have been working. Still, they are continuing to investigate and monitor the situation. The outbreak was traced back to cooling towers in the area. Cooling towers are a part of a building's air conditioning system that uses water to help cool it down. The city health department tested all the cooling towers in the affected areas and found that 12 of them had the bacteria. They have all since been cleaned and treated. Health officials have said that the issue is with the cooling towers, not with the regular hot or cold water in the buildings, and that it's safe for people to continue using their air conditioners. Can It Spread From Person To Person Contact? Legionnaires' disease is not contagious, so you can't get it from another person. The disease is mainly spread when someone breathes in tiny water droplets (called aerosols) that are contaminated with the Legionella bacteria. While it's not common, you can also be exposed by breathing in contaminated soil or, in rare cases, by accidentally breathing in water while drinking it. Whether a person gets sick after exposure depends on a few things: their overall health, how much of the bacteria is in the air they breathe, and how contaminated the source of the bacteria is. What Caused The Sudden Surge In Numbers? As of Monday, 14 people were hospitalized according to the health department. However, within the span of 5 days the number of infections has jumped to 108 people. Harlem City Councilmember Yusef Salaam, in a press conference last week urges people to visit the doctor if they exhibit any flu-like symptom to visit the doctor. "This is the time for you to actually go and seek medical attention. That's how serious this is." How Long Does It Take For Legionnaires Symptoms To Appear? Legionnaires’ disease is a serious type of lung infection, or pneumonia. People can get sick by breathing in tiny water droplets that contain the bacteria. The symptoms can take up to two weeks to appear and often feel like a bad case of the flu, including a cough, fever, chills, headaches, and muscle aches. The disease got its name from an outbreak in 1976 among a group of veterans at a convention. While the disease is not very common, it is becoming more of a concern nationwide, with research suggesting that hotter, more humid weather might be a reason for the increase in cases. 

legionnaires' outbreak sickened 108 and kills 5 in new york city: can it spread from person to person?

Olivia Munn Breast Cancer Lifetime Risk Assessment Test 2025, Details Inside

'Lifetime Risk Assessment Test' That Saved Olivia Munn's Life, Details Inside

Ortho Surgeon Reveals The Real Reason Behind This 29-Year-Old Woman's Stage 3 Fatty Liver Diagnosis - It Wasn't Alcohol

ortho surgeon reveals the real reason behind this 29-year-old woman's stage 3 fatty liver diagnosis - it wasn't alcohol

The Endometriosis Battle Finally Comes To An End For Bindi Irwin, As She Undergoes Removal Of 51 Lesions, Cyst, And Appendix

the endometriosis battle finally comes to an end for bindi irwin, as she undergoes removal of 51 lesions, cyst, and appendix

Jana Duggar Is Pregnant: Why the First Few Weeks of Pregnancy Matter More Than You Think

jana duggar is pregnant: why the first few weeks of pregnancy matter more than you think

More Than Just Shrinking The Tumour: Expert Tells How Neoadjuvant Therapy Changes The Game In Breast Cancer Treatment

more than just shrinking the tumour: expert tells how neoadjuvant therapy changes the game in breast cancer treatment

Olivia's Breast Cancer Journey (Oliviamunn/Instagram)

Actress <span>Olivia Munn</span> shared an intimate video from May 2023, just before she had a double mastectomy for <span>breast cancer</span>. The video, posted on Instagram for World Breast Cancer Research Day, shows Munn in her hospital bed with her husband, John Mulaney. He is sitting beside her, holding her hands. They press their foreheads together and speak in hushed tones, surrounded by the quiet sounds of the hospital. 

Munn wrote in her caption that this was her first of five surgeries in her "determined battle to beat breast cancer." 

One of the biggest aspects of her treatment was the “lifetime risk assessment test” she mentioned in her caption. “Please go to the link in bio to take the quick and free lifetime risk assessment test that saved my life.” 

<h2>What Is Lifetime Risk Assessment Test? </h2>

According to the MagView Tyrer-Cuzick Risk Assessment Calculator* in Munn’s bio, this test helps one calculate their lifetime risk of developing breast cancer. The tool urges people to reach out to their healthcare professional in case they have any questions about their risk of developing breast cancer and what are the best options for breast cancer screenings or genetic counseling they may have. 

The US National Cancer Institute also has an <span>Breast Cancer Risk Assessment Tool</span> (BCRAT) known as Gail Model, which helps healthcare professionals estimate a woman’s risk of developing invasive breast cancer over the next five year. The tool uses a person’s medical history as well as breast cancer history among the first-degree relatives to estimate theur risk of getting breast cancer

<h2>Olivia Munn’s Breast Cancer Journey </h2>

In her post caption, Munn details how she has gone through a double mastectomy, reconstruction surgery, a lymph node dissection, and a hysterectomy. She recently shared that her mother also received a breast cancer diagnosis two years after her own. 

Munn explained that both her and her mother's cancer are "very aggressive, fast-moving." However, she added that thanks to research funding, they both had a path to survival. For example, she said that endocrine therapy, a hormone treatment she is currently on, was discovered just 20 years ago. This treatment works by keeping hormones from reaching cancer cells. 

<b>Also Read: <a href="https://www.healthandme.com/health-wellness/world-mosquito-day-2025-dengue-transmission-isnt-one-way-humans-infect-mosquitoes-too-article-152494960" data-type="tilCustomLink" target="_blank">World Mosquito Day 2025: Dengue Transmission Isn’t One-Way, Humans Infect Mosquitoes Too</a></b>

<h2>Olivia Munn’s Message for Early Detection of Breast Cancer</h2> 

Munn emphasized that funding for breast cancer research has created treatment plans that give her and many others hope. She urged her followers to donate, saying that their contributions could save countless lives by helping to find cures and improve treatments. She also recommended supporting organizations like Susan G. Komen and the American Cancer Society, which have made a real impact. 

In her post, Munn also encouraged women to take the breast cancer assessment test. She discovered she had a 37% chance of breast cancer, which led to more tests that found her aggressive form of the disease. She stressed that any woman over 30 should take the test, and if their risk is above 20%, they should ask their doctor for a breast MRI. 

<h2>Who Should Get <span rel="noindex">Breast Cancer Screening</span> Done? </h2>

According to the American Cancer Society, you are considered to be at average risk if you do not have a personal history of breast cancer, a strong family history of it, or a known genetic mutation (like in the BRCA gene) that increases your risk. This also applies if you have not had chest radiation before the age of 30. These are the breast cancer screening recommendations for women who are average risk. 

<strong>Ages 40-44:</strong> You have the choice to start getting a mammogram every year. 

<strong>Ages 45-54:</strong> You should get a mammogram every year. 

<strong>Ages 55 and older:</strong> You can switch to getting a mammogram every other year, or you can choose to continue getting one every year. You should continue to get screened as long as you are in good health and are expected to live at least 10 more years. 

Keep in mind that these guidelines are for mammograms only. Clinical breast exams, which are physical exams done by a doctor or other healthcare professional, are not recommended for breast cancer screening in women at average risk. 

<em>*Please Note: The Magview Tyrer-Cuzick Risk Assessment Calculator is for non-commercial and non-clinical use, for a clinical diagnosis, please reach out to your healthcare professional.</em>

Olivia Munn

Breast cancer

Breast cancer screening

Breast Cancer Risk Assessment Tool

early breast cancer detection

Olivia Munn breast cancer

Actress Olivia Munn shared an intimate video from May 2023, just before she had a double mastectomy for breast cancer. The video, posted on Instagram for World Breast Cancer Research Day, shows Munn in her hospital bed with her husband, John Mulaney. He is sitting beside her, holding her hands. They press their foreheads together and speak in hushed tones, surrounded by the quiet sounds of the hospital. Munn wrote in her caption that this was her first of five surgeries in her "determined battle to beat breast cancer." One of the biggest aspects of her treatment was the “lifetime risk assessment test” she mentioned in her caption. “Please go to the link in bio to take the quick and free lifetime risk assessment test that saved my life.”           What Is Lifetime Risk Assessment Test? According to the MagView Tyrer-Cuzick Risk Assessment Calculator* in Munn’s bio, this test helps one calculate their lifetime risk of developing breast cancer. The tool urges people to reach out to their healthcare professional in case they have any questions about their risk of developing breast cancer and what are the best options for breast cancer screenings or genetic counseling they may have. The US National Cancer Institute also has an Breast Cancer Risk Assessment Tool (BCRAT) known as Gail Model, which helps healthcare professionals estimate a woman’s risk of developing invasive breast cancer over the next five year. The tool uses a person’s medical history as well as breast cancer history among the first-degree relatives to estimate theur risk of getting breast cancer                 View this post on Instagram            A post shared by o l i v i a (@oliviamunn)]]>Olivia Munn’s Breast Cancer Journey In her post caption, Munn details how she has gone through a double mastectomy, reconstruction surgery, a lymph node dissection, and a hysterectomy. She recently shared that her mother also received a breast cancer diagnosis two years after her own. Munn explained that both her and her mother's cancer are "very aggressive, fast-moving." However, she added that thanks to research funding, they both had a path to survival. For example, she said that endocrine therapy, a hormone treatment she is currently on, was discovered just 20 years ago. This treatment works by keeping hormones from reaching cancer cells. Also Read: World Mosquito Day 2025: Dengue Transmission Isn’t One-Way, Humans Infect Mosquitoes TooOlivia Munn’s Message for Early Detection of Breast Cancer Munn emphasized that funding for breast cancer research has created treatment plans that give her and many others hope. She urged her followers to donate, saying that their contributions could save countless lives by helping to find cures and improve treatments. She also recommended supporting organizations like Susan G. Komen and the American Cancer Society, which have made a real impact. In her post, Munn also encouraged women to take the breast cancer assessment test. She discovered she had a 37% chance of breast cancer, which led to more tests that found her aggressive form of the disease. She stressed that any woman over 30 should take the test, and if their risk is above 20%, they should ask their doctor for a breast MRI. Who Should Get Breast Cancer Screening Done? According to the American Cancer Society, you are considered to be at average risk if you do not have a personal history of breast cancer, a strong family history of it, or a known genetic mutation (like in the BRCA gene) that increases your risk. This also applies if you have not had chest radiation before the age of 30. These are the breast cancer screening recommendations for women who are average risk. Ages 40-44: You have the choice to start getting a mammogram every year. Ages 45-54: You should get a mammogram every year. Ages 55 and older: You can switch to getting a mammogram every other year, or you can choose to continue getting one every year. You should continue to get screened as long as you are in good health and are expected to live at least 10 more years. Keep in mind that these guidelines are for mammograms only. Clinical breast exams, which are physical exams done by a doctor or other healthcare professional, are not recommended for breast cancer screening in women at average risk.  *Please Note: The Magview Tyrer-Cuzick Risk Assessment Calculator is for non-commercial and non-clinical use, for a clinical diagnosis, please reach out to your healthcare professional.

'lifetime risk assessment test' that saved olivia munn's life, details inside

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

FDA Approves First Glucose Monitoring System For Weight Loss, But Should People Who Don’t Have Diabetes Wear It?

Quick Stories

Scientists Recreate Rare Mutation That Could Make You Nearly Immune To All Viruses

Legionnaires' Outbreak Sickened 108 And Kills 5 In New York City: Can It Spread From Person To Person?

Olivia Munn Breast Cancer Lifetime Risk Assessment Test 2025, Details Inside

Health Conditions A-Z

7 Minutes Of Life: The Science Behind What Happens To Your Brain After You Die

Scientists Recreate Rare Mutation That Could Make You Nearly Immune To All Viruses

Better Diet Could Help Defeat Tuberculosis, Says ICMR Study Backed by WHO